MCID: WST005
MIFTS: 45

West Nile Virus malady

Categories: Genetic diseases, Rare diseases

Aliases & Classifications for West Nile Virus

About this section

Aliases & Descriptions for West Nile Virus:

Name: West Nile Virus 49 45 35
West Nile Virus, Susceptibility to 11 24
 
West Nile Viral Infection 65

Classifications:



External Ids:

OMIM49 610379
UMLS65 C1096184

Summaries for West Nile Virus

About this section
MedlinePlus:35 West nile virus (wnv) is an infectious disease that first appeared in the united states in 1999. infected mosquitoes spread the virus that causes it. people who get wnv usually have no symptoms or mild symptoms. the symptoms include a fever, headache, body aches, skin rash, and swollen lymph glands. they can last a few days to several weeks, and usually go away on their own. if west nile virus enters the brain, however, it can be life-threatening. it may cause inflammation of the brain, called encephalitis, or inflammation of the tissue that surrounds the brain and spinal cord, called meningitis. a physical exam, health history and laboratory tests can diagnose it. older people and those with weakened immune systems are most at risk. there are no specific vaccines or treatments for human wnv disease. the best way to avoid wnv is to prevent mosquito bites: use insect repellent get rid of mosquito breeding sites by emptying standing water from flower pots, buckets or barrels stay indoors between dusk and dawn, when mosquitoes are most active use screens on windows to keep mosquitoes out nih: national institute of allergy and infectious diseases

MalaCards based summary: West Nile Virus, also known as west nile virus, susceptibility to, is related to hiv-1 and hepatitis b. An important gene associated with West Nile Virus is CCR5 (C-C Motif Chemokine Receptor 5 (Gene/Pseudogene)), and among its related pathways are Osteoblast Signaling and Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers. Affiliated tissues include brain, spinal cord and testes, and related mouse phenotypes are tumorigenesis and immune system.

OMIM:49 WNV is an enveloped, neurotropic, single-stranded sense RNA flavivirus that is naturally maintained in a zoonotic cycle... (610379) more...

Wikipedia:68 West Nile virus (WNV) is a mosquito-borne arbovirus of the Flavivirus kind in the family Flaviviridae.... more...

Related Diseases for West Nile Virus

About this section

Graphical network of the top 20 diseases related to West Nile Virus:



Diseases related to west nile virus

Symptoms for West Nile Virus

About this section


Clinical features from OMIM:

610379

Drugs & Therapeutics for West Nile Virus

About this section

Drugs for West Nile Virus (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 28)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Nitazoxanideapproved, investigationalPhase 34555981-09-441684
Synonyms:
(2-((5-Nitro-2-thiazolyl)carbamoyl)phenyl)acetat
2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide
2-Acetyloxy-N-[(5-nitro-2-thiazolyl)]benzamide
2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate
55981-09-4
AC-1302
AC1L26A1
AC1Q5NVY
AZT + Nitazoxanide
Adrovet
Alinia
Alinia (TN)
BRN 1225475
C12H9N3O5S
CHEMBL1401
CID41684
CPD000466367
Colufase
Cryptaz
D02486
DB00507
Daxon
Daxon, Dexidex, Kidonax, Pacovanton, Paramix, Nitax, Zox, Nitazoxanide
EINECS 259-931-8
FT-0082459
HMS2051L04
Heliton
I14-6011
LS-144176
MLS000759492
MLS001424074
MolPort-002-042-244
N-(5-Nitro-2-thiazolyl)salicylamide acetate (ester)
 
N-(5-Nitrothiazol-2-yl)salicylamide acetate ester
NCGC00090774-01
NCI60_034935
NCIMech_000843
NITAZOXANIDE
NSC 697855
NSC697855
Nitaxozanid
Nitaxozanide
Nitazoxanid
Nitazoxanida
Nitazoxanida [INN-Spanish]
Nitazoxanide (USAN/INN)
Nitazoxanide [USAN:INN]
Nitazoxanidum
Nitazoxanidum [INN-Latin]
Nodik
Omniparax
Oprea1_263587
Phavic-1
S1627_Selleck
SAM001246708
SBB068315
SMR000466367
STK395664
Salicylamide, N-(5-nitro-2-thiazolyl)- acetate (ester)
Salicylamide, N-(5-nitro-2-thiazolyl)-, acetate (ester)
Taenitaz
Tizoxanide Glucuronide
Tizoxanide glucuronide
UNII-SOA12P041N
ZINC03956788
[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate
azt+ nitazoxanide
o-(N-(5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate
2
OseltamivirapprovedPhase 393204255-11-865028
Synonyms:
(-)-Oseltamivir
(-)-oseltamivir
(3R,4R,5S)-4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid
(3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid
(−)-oseltamivir
196618-13-0
204255-11-8
4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid
AC1L22FK
AC1Q63H0
Agucort
Agucort (TN)
BIDD:GT0426
BRD-K76011241-045-01-5
C08092
CHEBI:7798
CHEMBL1229
CID65028
D08306
DB00198
Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate
Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate
FT-0082384
 
GS 4104
GS-4104
GS4104
HMS2090C11
HSDB 7433
LS-57422
MolPort-005-933-026
NCGC00178698-01
Oseltamivir
Oseltamivir (INN)
Oseltamivir [INN:BAN]
Oseltamivir phosphate
Oseltamivirum
Ro-64-0796
Ro-640796
Tamiflu
Tamiflu (*Phosphate salt 1:1*)
Tamiflu-Free
Tamvir
UNII-20O93L6F9H
ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate
oseltamivir
oseltamivirum
3Antiparasitic AgentsPhase 31854
4Heptavalent Pneumococcal Conjugate VaccinePhase 3, Phase 2440
5Anti-Infective AgentsPhase 317220
6Antiviral AgentsPhase 38071
7Immunologic FactorsPhase 3, Phase 1, Phase 218483
8
LactitolPhase 3320585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
9Pharmaceutical SolutionsPhase 3, Phase 1, Phase 27004
10VaccinesPhase 3, Phase 2, Phase 16085
11
CarboplatinapprovedPhase 2188541575-94-410339178, 498142, 38904
Synonyms:
(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum
/h1-3H2,(H,7,8)(H,9,10)
/q
1,1-Cyclobutanedicarboxylate diammine platinum (II)
1,1-Cyclobutanedicarboxylate diammine platinum(II)
2*-1
2*1H2
41575-94-4
70903-55-8
AC-1457
AC1L8I6U
Ambap41575-94-4
BSPBio_003145
C 2538
C2043
C2538_SIGMA
C6H10N2O4Pt
CBDCA
CCRIS 3404
CHEBI:31355
CHEMBL1351
CHEMBL288376
CID10339178
CID2567
CID38904
CID426756
CID498142
CID5352133
CID6398587
CID6603770
Carbopaltin
Carboplatin
Carboplatin (JAN/USP/INN)
Carboplatin (USAN)
Carboplatin [USAN:INN:BAN:JAN]
Carboplatine
Carboplatine [French]
Carboplatino
Carboplatino [Spanish]
Carboplatinum
Carboplatinum [Latin]
Cbdca
Cyclobutane-1,1-dicarboxylate
D01363
DB00958
Diammine(1,1-cyclobutanedicarboxylato)platinum (II)
Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum
Diammine-1,1-cyclobutane dicarboxylate platinum II
DivK1c_000892
EINECS 255-446-0
EU-0100230
Ercar
HMS1921J16
HMS2090M05
HMS2092B22
HMS502M14
HSDB 6957
I14-2390
IDI1_000892
IUPAC: Azane
InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6
 
JM 8
JM-8
KBio1_000892
KBio2_002009
KBio2_004577
KBio2_007145
KBio3_002645
KBioGR_000713
KBioSS_002009
LS-117689
Lopac-C-2538
Lopac0_000230
MolPort-003-665-501
MolPort-003-845-609
NCGC00015223-01
NCGC00093695-01
NCGC00094961-01
NCGC00094961-02
NCGC00094961-03
NCGC00162099-01
NCGC00162099-02
NCGC00167800-01
NCGC00178242-01
NINDS_000892
NSC 201345
NSC 241240
NSC-241240
NSC201345
NSC241240
Paraplatin
Paraplatin (TN)
Paraplatin, Carboplatin
Paraplatin-AQ
Platinum(+2) Cation
Platinum(II), (1, 1-cyclobutanedicar
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)
Platinum, {diammine[1,1-cyclobut
S1215_Selleck
SPBio_000716
SPECTRUM1502106
Spectrum2_000898
Spectrum3_001503
Spectrum4_000337
Spectrum5_001094
Spectrum_001529
UNII-BG3F62OND5
azanide
carboplatin
cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II)
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(ii)
cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II)
cis-Diammine(1,1-cyclobutanedicarboxylato) platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diammine(cyclobutanedicarboxylato)platinum II
cyclobutane-1,1-dicarboxylic acid
diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum
nchembio.573-comp10
nchembio773-comp2
nchembio873-comp3
platinum(2+)
12
PaclitaxelapprovedPhase 2262133069-62-436314
Synonyms:
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
157069-30-2
33069-62-4
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.
7-Epi-Paclitaxel
7-Epi-Taxol
7-Epipaclitaxel
7-Epitaxol
7-epi-Paclitaxel
7-epi-Taxol
AB00513812
ABI 007
ABI-007
ABI007
AC-675
AC1L1IOG
AC1L1VJI
AC1L9AVF
ACon1_002231
ANX-513
Abraxane
Abraxane (TN)
Abraxane I.V. Suspension
Abraxis BioScience brand of albumin-bound paclitaxel
Ambotz33069-62-4
Anzatax
Asotax
BIDD:PXR0046
BMS 181339-01
BMS-181339
BMS-181339-01
BPBio1_000320
BRD-A23723433-001-01-2
BRD-A28746609-001-04-0
BRD-K62008436-001-03-1
BSPBio_000290
BSPBio_001152
BSPBio_002614
Bio-0076
Bio1_000362
Bio1_000851
Bio1_001340
Bio2_000416
Bio2_000896
Bristaxol
C07394
C466458
C47H51NO14
CCRIS 8143
CHEBI:103439
CHEBI:45863
CHEMBL100910
CHEMBL418410
CHEMBL48
CID36314
CID441276
CID4666
CID6713921
CID6915727
CPD-8718
Capxol
D00491
DB01229
DHP-107
DHP-208
DRG-0190
DTS-301
DivK1c_000441
EU-0101201
Ebetaxel
EmPAC
Epitaxol
Genaxol
Genetaxyl
Genexol
Genexol-PM
HMS1362J13
HMS1568O12
HMS1792J13
HMS1922K08
HMS1990J13
HMS2090D07
HMS2093K15
HMS501G03
HSDB 6839
I06-0014
IDI1_000441
IDI1_002171
Intaxel
KBio1_000441
KBio2_000492
KBio2_002016
KBio2_002509
KBio2_003060
KBio2_004584
KBio2_005077
KBio2_005628
KBio2_007152
KBio2_007645
KBio3_000903
KBio3_000904
KBio3_001834
KBio3_002987
KBioGR_000492
KBioGR_001893
 
KBioGR_002509
KBioSS_000492
KBioSS_002016
KBioSS_002517
LMPR0104390001
LS-31070
LipoPac
Lopac0_001201
MBT 0206
MEGxp0_001940
MLS000863266
MLS001077297
MLS002154218
MLS002172439
MLS002695976
MPI-5018
Micellar Paclitaxel
Mitotax
MolPort-001-742-627
MolPort-003-665-783
MolPort-003-932-365
NCGC00024995-02
NCGC00024995-03
NCGC00024995-04
NCGC00024995-05
NCGC00024995-06
NCGC00024995-07
NCGC00164367-01
NCGC00164367-02
NCGC00164367-03
NCI60_000601
NINDS_000441
NK 105
NP-010981
NSC 125973
NSC-125973
NSC125973
NSC358882
Nanotaxel
Neuro_000060
Nova-12005
OAS-PAC-100
OncoGel
Onxal
Onxol
Onxol, Taxol, Nov-Onxol, Paclitaxel
P1632
Paclical
Pacligel
Paclitaxel
Paclitaxel (JAN/USP)
Paclitaxel (JAN/USP/INN)
Paclitaxel (Taxol)
Paclitaxel [USAN:INN:BAN]
Paxceed
Paxene
Paxoral
Plaxicel
Praxel
Prestwick0_000155
Prestwick1_000155
Prestwick2_000155
Prestwick3_000155
Probes2_000350
QW 8184
S-8184 Paclitaxel Injectable Emulsion
S1150_Selleck
SDCCGMLS-0066823.P001
SDP-013
SMP1_000228
SMR000394086
SMR000857385
SPBio_000943
SPBio_002229
SPECTRUM1503908
ST50306996
Spectrum2_000872
Spectrum3_001057
Spectrum4_001197
Spectrum5_001491
Spectrum_001536
T 7402
T1912_SIGMA
T7191_SIGMA
T7402_SIGMA
TA1
TAXOL (TN)
TAXOL, 10-EPI,
TXL
TaxAlbin
Taxol
Taxol A
Taxol Konzentrat
Taxol.RTM. (Registered Trademark)
UNII-P88XT4IS4D
UPCMLD-DP108:001
UPCMLD-DP108:002
Vascular Wrap
Xorane
Yewtaxan
abi-007
albumin-bound paclitaxel
cMAP_000068
nchembio.188-comp1
nchembio.2007.34-comp9
nchembio.215-comp9
nchembio853-comp6
paclitaxel
weekly paclitaxel
13
RibavirinapprovedPhase 294836791-04-537542
Synonyms:
1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide
36791-04-5
437710-49-1
66510-90-5
AA-504/07617051
AB00430481
AC1L1XXZ
AC1Q1IDC
AC1Q4ZGS
AKOS001715163
BB_NC-0567
BPBio1_001195
BRN 0892462
BSPBio_001085
BSPBio_003352
C-Virin
CHEMBL1643
CID37542
Copegus
Copegus (TN)
Cotronak
D00423
DB00811
DRG-0028
DivK1c_000782
Drug: Ribavirin
EU-0101063
FT-0082885
HMS2090L15
HMS2094O09
HMS502H04
HSDB 6513
ICN-1229
IDI1_000782
Ibavyr
KBio1_000782
KBio2_002328
KBio2_004896
KBio2_007464
KBio3_002854
KBioGR_001804
KBioSS_002331
KS-1104
LS-1241
Lopac0_001063
MLS000028486
MLS002222317
Moderiba
MolPort-002-507-104
MolPort-002-885-856
NCGC00090726-01
NCGC00090726-03
NCGC00090726-04
NCGC00090726-05
NCGC00090726-06
NCGC00090726-07
NINDS_000782
 
NSC 163039
NSC163039
Prestwick3_000993
R 9644
R-964
R9644_SIGMA
RBV
RG-964
RIBAV
RTC
RTCA
RTP
Ravanex
Rebetol
Rebetol (TN)
Rebetron
Rebretron
Ribacine
Ribamide
Ribamidil
Ribamidyl
Ribasphere
Ribasphere (TN)
Ribasphere Ribapak
Ribav
Ribavirin
Ribavirin (JAN/USP/INN)
Ribavirin Capsules
Ribavirin Triphosphate
Ribavirin [USAN:INN]
Ribavirin-TP
Ribavirina
Ribavirina [INN-Spanish]
Ribavirine
Ribavirine [INN-French]
Ribavirinum
Ribavirinum [INN-Latin]
Ribovirin
Ro 20-9963/000
Ro-20-9963
S2504_Selleck
SCH 18908
SMP1_000261
SMR000058315
SPECTRUM1503938
SR-01000076112-3
Spectrum3_001876
Spectrum4_001252
Spectrum5_002075
Spectrum_001826
Tribavirin
UNII-49717AWG6K
Varazid
Vilona
Viramid
Viramide
Virazid
Virazide
Virazole
Virazole (Ribavirin) Inhalation Solution
Virazole (TN)
Virazole 5'-triphosphate
ZINC01035331
ribavirin
14
Glycineapproved, nutraceuticalPhase 1, Phase 29456-40-6750
Synonyms:
(1-13c)glycinato
(15N)Glycine
15527_RIEDEL
15527_SIAL
15743-44-9 (mono-potassium salt)
17829-66-2 (cobalt salt)
18875-39-3
2,2-dialkylglycines
2-Aminoacetate
2-Aminoacetic acid
2311-65-1
25718-94-9
29728-27-6 (monoammonium salt)
32817-15-5 (copper salt)
33226_RIEDEL
33226_SIAL
33242-26-1 (calcium salt)
35947-07-0 (calcium salt (2:1))
410225_SIAL
50046_FLUKA
50046_SIGMA
513-29-1 (sulfate (3:1))
52955-63-2
56-40-6
57678-19-0
6000-43-7 (hydrochloride)
6000-44-8 (mono-hydrochloride salt)
63183-41-5 (hydrochloride hydrogen carbonate)
71295-98-2 (phosphate (1:1))
7490-95-1 (hydrochloride (2:1)
7490-95-1 (hydrochloride (2:1))
7575-55-5
848646-45-7
87867-94-5
AB-131/40217813
AB1002628
AC1L19XW
AC1Q28JW
AC1Q53O0
AI3-04085
AKOS000119626
AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER
AR-1A0345
AR-1A0532
Acide aminoacetique
Acide aminoacetique [INN-French]
Acido aminoacetico
Acido aminoacetico [INN-Spanish]
Acidum aminoaceticum
Acidum aminoaceticum [INN-Latin]
Aciport
Amino-Acetate
Amino-Acetic acid
Aminoacetate
Aminoacetic acid
Aminoazijnzuur
Aminoessigsaeure
Aminoethanoate
Aminoethanoic acid
Amitone
B72BA06C-60E9-4A83-A24A-A2D7F465BB65
BPBio1_001222
Biomol-NT_000195
C00037
CCRIS 5915
CHEBI:15428
CHEBI:15705
CHEBI:16228
CHEMBL773
CID750
CPD-8569
Corilin
D00011
DB00145
EINECS 200-272-2
 
FEMA No. 3287
FT-0083159
G
G0099
G0317
G5417_SIGMA
G5523_SIGMA
G7126_SIGMA
G7403_SIGMA
G8790_SIGMA
G8898_SIGMA
GLY (IUPAC abbrev)
GLYCINE 1.5% IN PLASTIC CONTAINER
GLYCINE, ACS
Glicina
Glicina [INN-Spanish]
Glicoamin
Gly
Glycin
Glycine
Glycine (JP15/USP)
Glycine [INN]
Glycine iron sulphate (1:1)
Glycine, homopolymer (VAN)
Glycine, labeled with carbon-14
Glycine, non-medical
Glycine-UL-14C hydrochloride
Glycinum
Glycinum [INN-Latin]
Glycocoll
Glycolixir
Glycosthene
Glykokoll
Glyzin
Gyn-Hydralin
Gyn-hydralin
H-Gly-OH
H2N-CH2-COOH
HSDB 495
Hampshire glycine
Hgly
InChI=1/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5
KST-1A2919
KST-1A8102
L-Glycine
L-alpha-amino acids
L001246
LS-218
Leimzucker
MolPort-000-871-607
NCGC00024503-01
NCGC00024503-02
NChemBio.2007.13-comp1
NSC 25936
NSC25936
P8791_SIGMA
Padil
Polyglycine II
S04-0135
Sucre de gelatine
Tocris-0219
UNII-TE7660XO1C
W328707_ALDRICH
WLN: Z1VQ
aminoacetic acid
an alpha amino acid ester
bmse000089
gly
glycine
nchem.554-comp2
nchembio.121-comp9
nchembio.145-comp33
nchembio.198-comp12
nchembio.265-comp9
nchembio.266-comp30
polyglycine
15Albumin-Bound PaclitaxelPhase 22621
16Antibodies, MonoclonalPhase 2, Phase 12413
17Immunoglobulins, IntravenousPhase 2, Phase 1211
18AntibodiesPhase 2, Phase 14477
19Immunoglobulin GPhase 2, Phase 1146
20ImmunoglobulinsPhase 2, Phase 14477
21Rho(D) Immune GlobulinPhase 2, Phase 1206
22Gamma-GlobulinsPhase 1, Phase 222
23
Aluminum hydroxideapprovedPhase 1178
Synonyms:
Al(OH)3
Aluminiumhydroxid
 
Aluminum Hydroxide
Aluminum hydroxide
Dermadrox
24Aluminum sulfatePhase 179
25
Natalizumabapproved, investigational93189261-10-7
Synonyms:
189261-10-7
Anti-VLA4
Anti-alpha4 integrin
 
D06886
Natalizumab
Natalizumab (INN)
Tysabri
Tysabri (TN)
26
Pancrelipaseapproved88053608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
Creon
PA
Pancreatic alpha-amylase precursor
Pancreaze
 
Pancrelipase
Pertzye
Polocaine-mpf
Ultresa
Viokace
Zenpep
27Gastrointestinal Agents6401
28pancreatin880

Interventional clinical trials:

(show all 38)
idNameStatusNCT IDPhase
1Organ Transplant Infection Prevention and Detection ProjectCompletedNCT00177801Phase 4
2Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy InfantsCompletedNCT00806195Phase 3
3Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of AgeCompletedNCT02184572Phase 3
4A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 MonthsCompletedNCT01000311Phase 3
5A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in ChildrenCompletedNCT01091246Phase 3
6Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy ToddlersCompletedNCT00422292Phase 3
7Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female SubjectsCompletedNCT00369824Phase 3
8Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated InfluenzaCompletedNCT01610245Phase 3
9Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus DiseaseCompletedNCT00069316Phase 2
10IVIG - West Nile Encephalitis: Safety and EfficacyCompletedNCT00068055Phase 1, Phase 2
11Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy AdultsCompletedNCT00746798Phase 2
12Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy AdultsCompletedNCT00442169Phase 2
13Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese EncephalitisCompletedNCT01856205Phase 2
14Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of AgeCompletedNCT00578175Phase 2
15Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx CancerCompletedNCT00014118Phase 2
16Treatment of Japanese EncephalitisRecruitingNCT00216268Phase 2
17Treatment of West Nile Virus With MGAWN1TerminatedNCT00927953Phase 2
18Phase I Study of West Nile Virus VaccineCompletedNCT00300417Phase 1
19Vaccine to Prevent West Nile Virus DiseaseCompletedNCT00106769Phase 1
20A Trial to Evaluate the Safety of a Single Intravenous Infusion of MGAWN1 in Healthy AdultsCompletedNCT00515385Phase 1
21Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy AdultsCompletedNCT00094718Phase 1
22Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020CompletedNCT00387283Phase 1
23Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy AdultsCompletedNCT00537147Phase 1
24Safety Study of HBV-002 West Nile Vaccine in Healthy AdultsCompletedNCT00707642Phase 1
25Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal FluidCompletedNCT00381433Phase 1
26Phase 1 Trial of Inactivated West Nile Virus VaccineActive, not recruitingNCT02337868Phase 1
27Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of AgeActive, not recruitingNCT02186626Phase 1
28An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) DiseaseTerminatedNCT00091845Phase 1
29West Nile Virus Natural HistoryCompletedNCT00138463
30Natural History of West Nile Virus InfectionCompletedNCT00069303
31Retrovirus Epidemiology Donor Study-II (REDS-II)CompletedNCT00097006
32Surveillance of Summer Febrile Syndromes of Viral Origin in South of FranceCompletedNCT00842166
33VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious DiseasesCompletedNCT00068926
34JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With NatalizumabCompletedNCT01070836
35An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature InfantsCompletedNCT00983606
36Cohort of Patients Infected by an ArbovirusRecruitingNCT01099852
37Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement TherapyRecruitingNCT01858519
38Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental ExposureNo longer availableNCT01206504

Search NIH Clinical Center for West Nile Virus

Genetic Tests for West Nile Virus

About this section

Anatomical Context for West Nile Virus

About this section

MalaCards organs/tissues related to West Nile Virus:

33
Brain, Spinal cord, Testes, Skin, T cells, Breast, Lung

Animal Models for West Nile Virus or affiliated genes

About this section

MGI Mouse Phenotypes related to West Nile Virus:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.8CCR5, DDX58, ITGAV, ITGB3, STAT1, TLR3
2MP:00053877.3CCR5, CLEC4M, DDX58, IFIH1, IFITM3, IRF3

Publications for West Nile Virus

About this section

Articles related to West Nile Virus:

(show top 50)    (show all 688)
idTitleAuthorsYear
1
Neuraminidase-1 mediates skeletal muscle regeneration. (26001931)
2015
2
Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. (25404854)
2014
3
Contact dermatitis: Allergic and irritant. (24314385)
2014
4
Role of fractalkine in the pathogenesis of primary SjAPgren syndrome: increased serum levels of fractalkine, its expression in labial salivary glands, and the association with clinical manifestations. (25320221)
2014
5
Low grade glioma in an adult patient with Sotos syndrome. (25304431)
2014
6
Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis. (24676037)
2014
7
Effect of Qingxuan Granule () on blood pressure variability of hypertensive patients with and without obstructive sleep apnea. (24126974)
2013
8
Extended surgery for retroperitoneal sarcoma: too much surgery for some and not enough for others? Con. (23977758)
2013
9
Patent ductus arteriosus in an adult amur leopard (Panthera pardus orientalis). (23505729)
2013
10
The heritability of clinically diagnosed attention deficit hyperactivity disorder across the lifespan. (24107258)
2013
11
Republished review: Ocular manifestations of the antiphospholipid syndrome. (21705776)
2011
12
Hypoplastic left heart syndrome with intact atrial septum sequelae of left atrial hypertension in utero. (21565633)
2011
13
Maternal muscle mass may influence system A activity in human placenta. (20206993)
2010
14
Use of calcium hydroxylapatite for management of recalcitrant otorrhea due to a patulous eustachian tube. (21035198)
2010
15
The role of MT2-MMP in cancer progression. (20117087)
2010
16
Monocytes from children with clinically stable cystic fibrosis show enhanced expression of Toll-like receptor 4. (20717938)
2010
17
Non-tuberculous mycobacterial pleurisy: an 8-year single-centre experience in Taiwan. (20392359)
2010
18
A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. (18946481)
2009
19
Functional specificities of Brm and Brg-1 Swi/Snf ATPases in the feedback regulation of hepatic bile acid biosynthesis. (19805516)
2009
20
Rap1 maintains adhesion between cells to affect Egfr signaling and planar cell polarity in Drosophila. (19576205)
2009
21
Solution structure and glycophorin C binding studies of the protein 4.1R FERM alpha-lobe domain. (19338061)
2009
22
Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes. (18677713)
2009
23
Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review. (19861519)
2009
24
Comparative genomic analyses of nickel, cobalt and vitamin B12 utilization. (19208259)
2009
25
Redox regulation of methylthioadenosine phosphorylase in liver cells: molecular mechanism and functional implications. (18237276)
2008
26
Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition. (19808299)
2008
27
Acetylcholine esterase activity in mild cognitive impairment and Alzheimer's disease. (18196237)
2008
28
HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome? (18729532)
2008
29
Reduced expression of the sarcoplasmic calcium pump SERCA2 in skeletal muscle from patients with chronic obstructive pulmonary disease and low body weight]. (17257557)
2007
30
Diagnosis and treatment of disseminated intravascular coagulation: a case report. (17604485)
2007
31
Enhanced oxidation of NAD(P)H by oxidants in the presence of dehydrogenases but no evidence for a superoxide-propagated chain oxidation of the bound coenzymes. (17015264)
2006
32
Nordihydroguaiaretic acid inhibits IFN-gamma-induced STAT tyrosine phosphorylation in rat brain astrocytes. (15694390)
2005
33
Effect of long-term and high-dose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis. (15343012)
2004
34
Induction of transcription by p21Waf1/Cip1/Sdi1: role of NFkappaB and effect of non-steroidal anti-inflammatory drugs. (15190207)
2004
35
A randomized, double-blind, parallel-group study comparing the analgesic effect of etoricoxib to placebo, naproxen sodium, and acetaminophen with codeine using the dental impaction pain model. (15100590)
2004
36
The eukaryotic translation initiation factor 4GI is cleaved by different retroviral proteases. (14610163)
2003
37
Collagen-binding mode of vWF-A3 domain determined by a transferred cross-saturation experiment. (12447349)
2003
38
Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. (11530153)
2001
39
The insulin sensitivity concept]. (11452210)
2001
40
Alteration in the choice of DNA repair pathway with increasing sequence selective DNA alkylation in the minor groove. (10980446)
2000
41
Photoreceptor localization of the KIF3A and KIF3B subunits of the heterotrimeric microtubule motor kinesin II in vertebrate retina. (10548469)
1999
42
Thrombin receptor overexpression in malignant and physiological invasion processes. (9701242)
1998
43
Postoperative bleeding with factor VII deficiency: case report. (9973704)
1998
44
Case records of the Department of Medicine University of Mississippi Medical Center. Chronic active hepatitis with cirrhosis of liver secondary to alpha-1 antitrypsin deficiency. (9150671)
1997
45
IL-10 plays a role in the modulation of human granulomatous hypersensitivity against Schistosoma mansoni eggs induced by immune complexes. (9246214)
1997
46
Insulin resistance and arteriosclerosis obliterans in patients with NIDDM. (9353618)
1997
47
Gi alpha-1 expression in the human thyroid is regulated by TSH: loss of regulation in thyroid autonomous adenoma. (1284336)
1992
48
Insulin pen in the treatment of childhood diabetes]. (1412264)
1992
49
The demonstration of vasodilator activity of pancreatic amylin amide in the rabbit. (2316620)
1990
50
Intracellular phenylalanine and tyrosine concentration in homozygotes and heterozygotes for phenylketonuria (PKU) and hyperphenylalaninemia compared with normals. (7106768)
1982

Variations for West Nile Virus

About this section

Expression for genes affiliated with West Nile Virus

About this section
Search GEO for disease gene expression data for West Nile Virus.

Pathways for genes affiliated with West Nile Virus

About this section

Pathways related to West Nile Virus according to GeneCards Suite gene sharing:

(show all 18)
idSuper pathwaysScoreTop Affiliating Genes
110.0ITGAV, ITGB3
29.8CD209, ITGAV, ITGB3
39.7ITGAV, ITGB3, TLR3
49.6CD209, CLEC4M, ITGAV, ITGB3
59.5ITGAV, ITGB3, STAT1
6
Show member pathways
9.4ITGAV, STAT1, TLR3
7
Show member pathways
9.1DDX58, IFIH1, IFNA1, IRF3
89.0CD209, CLEC4M, IFNA1, STAT1
9
Show member pathways
8.9DDX58, IRF3, MX1, OAS1, STAT1
10
Show member pathways
8.9DDX58, IFIH1, IFNA1, IRF3, TLR3
11
Show member pathways
8.7CD209, IFNA1, IRF3, STAT1, TLR3
128.4DDX58, IFNA1, IRF3, OAS1, STAT1, TLR3
13
Show member pathways
8.3DDX58, IFIH1, IFNA1, IRF3, STAT1, TLR3
14
Show member pathways
7.5DDX58, IFIH1, IFITM1, IFNA1, IRF3, ITGAV
15
Show member pathways
7.2IFITM1, IFITM2, IFITM3, IFNA1, IRF3, MX1
16
Show member pathways
6.9DDX58, IFITM1, IFITM2, IFITM3, IFNA1, IRF3
17
Show member pathways
6.8CD209, CLEC4M, DDX58, IFIH1, IFNA1, IRF3
18
Show member pathways
5.3CD209, DDX58, IFIH1, IFITM1, IFITM2, IFITM3

GO Terms for genes affiliated with West Nile Virus

About this section

Cellular components related to West Nile Virus according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1filopodium membraneGO:003152710.0ITGAV, ITGB3

Biological processes related to West Nile Virus according to GeneCards Suite gene sharing:

(show all 21)
idNameGO IDScoreTop Affiliating Genes
1apolipoprotein A-I-mediated signaling pathwayGO:003802710.7ITGAV, ITGB3
2negative regulation of lipoprotein metabolic processGO:005074810.7ITGAV, ITGB3
3MDA-5 signaling pathwayGO:003953010.6IFIH1, IRF3
4response to exogenous dsRNAGO:004333010.6IRF3, TLR3
5regulation of type III interferon productionGO:003434410.5DDX58, IFIH1
6cytoplasmic pattern recognition receptor signaling pathway in response to virusGO:003952810.5DDX58, IFIH1
7type I interferon signaling pathwayGO:006033710.5IFITM2, IRF3
8positive regulation of interleukin-8 productionGO:003275710.4DDX58, TLR3
9detection of virusGO:000959710.3IFIH1, TLR3
10positive regulation of interferon-alpha productionGO:003272710.3DDX58, IFIH1, IRF3
11positive regulation of interferon-beta productionGO:003272810.2IFIH1, IRF3, TLR3
12viral entry into host cellGO:004671810.1CCR5, ITGAV, ITGB3
13response to biotic stimulusGO:000960710.1IFITM1, IFITM2
14response to interferon-gammaGO:00343419.8IFITM2, IFITM3
15defense responseGO:00069529.6IFNA1, MX1, TLR3
16response to interferon-betaGO:00354569.6IFITM1, IFITM2, IFITM3, STAT1
17negative regulation of viral genome replicationGO:00450719.5C19orf66, RSAD2
18innate immune responseGO:00450878.8CD209, CLEC4M, DDX58, IFIH1, MX1, TLR3
19cytokine-mediated signaling pathwayGO:00192218.7IFITM1, IFITM2, IFITM3, IFNA1, IRF3, STAT1
20response to virusGO:00096158.3DDX58, IFITM1, IFITM2, IFITM3, MX1, OAS1
21defense response to virusGO:00516076.8IFITM1, IFITM2, IFITM3, IFNA1, MX1, OAS1

Molecular functions related to West Nile Virus according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1hydrolase activity, acting on acid anhydridesGO:00168179.9DDX58, IFIH1
2virus receptor activityGO:00016189.5CD209, CLEC4M, ITGB3

Sources for West Nile Virus

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet